| 492 |
Centers for Disease Control and Prevention |
Html |
en |
Ten FAQs for Immunization Programs and Providers |
Content on this page was developed during the 2009-2010 H1N1 pandemic and has not been updated. |
| influenza vaccine | 0.975919 |
| trivalent inactivated influenza | 0.22802 |
| doses | 0.520847 |
| influenza vaccines | 0.260295 |
| vaccines | 0.286904 |
| monovalent inactivated vaccine | 0.326206 |
| monovalent influenza vaccines | 0.243591 |
| influenza vaccine schedule | 0.232409 |
| H1N1 monovalent influenza | 0.713668 |
| live attenuated vaccine | 0.275551 |
| seasonal influenza vaccination | 0.236339 |
|
| influenza vaccine trials | 0.227702 |
| dose | 0.258497 |
| inactivated influenza vaccine | 0.385678 |
| monovalent influenza vaccine | 0.707417 |
| immune response | 0.203409 |
| H1N1 monovalent LAIV | 0.915426 |
| seasonal laiv | 0.417086 |
| attenuated influenza vaccine | 0.219103 |
| influenza vaccine availability | 0.209417 |
| H1N1 monovalent vaccine | 0.489942 |
| seasonal influenza vaccine | 0.391152 |
|
CLICK HERE |
| 932 |
Centers for Disease Control and Prevention |
Html |
en |
ATSDR's Toxic Substances Portal | CDC Features |
ATSDR's Toxic Substances Web Portal makes it easy for researchers and citizens to find information about toxic chemicals and related health effects. Learn how toxic substances can affect health and how to prevent exposure. |
| toxic substance profile | 0.512361 |
| toxic chemicals | 0.469049 |
| Toxic Substances Web | 0.691075 |
| volatile organic compounds | 0.405221 |
| United States | 0.369281 |
| prior knowledge | 0.361617 |
| national priorities | 0.369213 |
| comprehensive access | 0.362452 |
| Toxic Substance Portal | 0.539211 |
| chemical substances | 0.509628 |
| toxic substance information | 0.56005 |
| medical education courses | 0.403949 |
| peer-reviewed scientific literature | 0.400755 |
| Chemical class | 0.361555 |
| Liability Act | 0.365066 |
| primary care providers | 0.405727 |
| Toxic Substances Portal | 0.830891 |
| specific health effects | 0.451422 |
| adverse health effects | 0.437716 |
| Superfund Act | 0.366736 |
| one-stop shop | 0.362244 |
| toxic substances | 0.931493 |
| specific information | 0.370881 |
| accurate information | 0.368788 |
|
| Public Health Statements | 0.424331 |
| exposure health effects | 0.451559 |
| public health professionals | 0.428175 |
| best science | 0.362224 |
| plain language summary | 0.402368 |
| health hazards | 0.382562 |
| Chemical Abstract Service | 0.412585 |
| latest research | 0.362178 |
| hazardous substances | 0.668407 |
| health risk levels | 0.427821 |
| search engine | 0.359511 |
| ATSDR publications | 0.408041 |
| Comprehensive Environmental Response | 0.421513 |
| clinical health effects | 0.439301 |
| health effects information | 0.461587 |
| CAS number | 0.36013 |
| sudden chemical exposure | 0.422507 |
| emergency department physicians | 0.404755 |
| toxicological profiles | 0.437041 |
| self-instructional courses | 0.361253 |
| Environmental Protection Agency | 0.431108 |
| easy click access | 0.40898 |
| Disease Registry | 0.37013 |
|
CLICK HERE |
| 5355 |
Centers for Disease Control and Prevention |
Html |
en |
Maintain a Healthy State of Mind - Seniors |
Information on preparing for public health emergencies from the Centers for Disease Control and Prevention (CDC). Get a kit, make a plan, and be informed. |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6519 |
Centers for Disease Control and Prevention |
Html |
en |
Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males - Advisory Committee on Immunization Practices (ACIP), 2011 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| male vaccination | 0.505695 |
| papillomavirus vaccination programme | 0.473747 |
| HPV vaccine coverage | 0.637457 |
| vaccine efficacy | 0.681465 |
| HPV types | 0.604301 |
| male HPV vaccination | 0.548522 |
| human papillomavirus disease | 0.48545 |
| papillomavirus recombinant vaccine | 0.493949 |
| prevention | 0.499642 |
| 3-dose series | 0.493433 |
| high efficacy | 0.623801 |
| HPV vaccine type | 0.588222 |
| males | 0.748102 |
| hpv vaccination | 0.621901 |
| HPV4 vaccination | 0.469425 |
| human papillomavirus vaccine | 0.566179 |
| intraepithelial neoplasia | 0.466264 |
| United States | 0.857612 |
| 18-associated cancers | 0.465512 |
| respective HPV type | 0.621613 |
| HPV vaccine types | 0.639395 |
| female-only vaccination | 0.46399 |
| HPV vaccine | 0.709612 |
| current vaccine price | 0.475724 |
|
| vaccine doses | 0.476855 |
| HPV | 0.773675 |
| genital warts | 0.980504 |
| anal cancers | 0.506609 |
| quadrivalent human papillomavirus | 0.79538 |
| efficacy trial | 0.499568 |
| ACIP | 0.478968 |
| 11-related genital warts | 0.471754 |
| 3-dose vaccine coverage | 0.529446 |
| DR. HPV Prophylactic | 0.483804 |
| clinical efficacy data | 0.489161 |
| 18-related genital warts | 0.561208 |
| anal cancer | 0.521837 |
| sexually active males | 0.496372 |
| human papillomavirus vaccination | 0.584607 |
| efficacy | 0.685612 |
| Nononcogenic HPV types | 0.512366 |
| clinical trial data | 0.470307 |
| routine vaccination | 0.46895 |
| Vaccine Safety Datalink | 0.545232 |
| vaccine | 0.779028 |
| Bivalent HPV vaccine | 0.628172 |
| HPV Vaccination Program | 0.604267 |
| et al | 0.577919 |
|
CLICK HERE |
| 7474 |
Centers for Disease Control and Prevention |
Html |
en |
NCEH A to Z Index - D |
Resources for the National Center for Environmental Health |
| Microsoft PowerPoint file | 0.432972 |
| Laboratory Sciences | 0.402289 |
| ePub file | 0.361191 |
| Audio/Video file | 0.348846 |
| Fact Sheets | 0.395441 |
| NCEH Budget Information | 0.502848 |
| Microsoft Word file | 0.436426 |
| Data Resources | 0.40406 |
| Environmental Health Services | 0.786539 |
| Building Healthy Places | 0.402936 |
| Clifton Road Atlanta | 0.377895 |
| Human Health Sciences | 0.473076 |
| State Fact Sheets | 0.388163 |
| Microsoft Excel file | 0.430574 |
| National Center | 0.478937 |
| Tweet Share Compartir | 0.434679 |
| Environmental Health | 0.973836 |
| list Skip | 0.363961 |
| State-of-the-Art Laboratory Methods | 0.408462 |
| page options Skip | 0.472568 |
| different file formats | 0.433871 |
| Improving Laboratory Tests | 0.406462 |
| Environmental Health Laboratory | 0.525615 |
| Apple Quicktime file | 0.425016 |
| Safe Water Programs | 0.388395 |
|
| Health Initiative | 0.364155 |
| CDC A-Z | 0.471817 |
| National Asthma Control | 0.397192 |
| RealPlayer file | 0.351056 |
| Health Effects | 0.442824 |
| Adobe PDF file | 0.427293 |
| Emergency Response | 0.310731 |
| Poisoning Prevention Program | 0.390151 |
| Environmental Public Health | 0.510808 |
| Environmental Health A-Z | 0.579774 |
| Search Form Controls | 0.632535 |
| Books/Booklets Healthy Housing | 0.387913 |
| Environmental Hazards | 0.432655 |
| A-Z Index | 0.565777 |
| National Report | 0.32332 |
| Environmental Health Topics | 0.520218 |
| Divisions Division | 0.31793 |
| Search Controls | 0.446493 |
| Healthy Housing Inspection | 0.387594 |
| Text file | 0.35302 |
| Environmental Concerns | 0.357835 |
| NCEH Press Room | 0.497902 |
| Disaster Epidemiology | 0.310636 |
| RIS file | 0.359193 |
|
CLICK HERE |
| 9645 |
Centers for Disease Control and Prevention |
Html |
en |
Estimating Meningitis Hospitalization Rates for SentinelHospitals Conducting Invasive Bacterial Vaccine-PreventableDiseases Surveillance |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| pneumococcal meningitis incidence | 0.474147 |
| childhood immunization programs | 0.325375 |
| surveillance network countries | 0.302021 |
| meningitis case | 0.396518 |
| meningitis surveillance | 0.550372 |
| children | 0.344778 |
| Bacterial Vaccine-Preventable Diseases | 0.328188 |
| pneumococcal conjugate vaccine | 0.342687 |
| WHO-coordinated IB-VPD sentinel | 0.416745 |
| World Health Organization | 0.574952 |
| IB-VPD surveillance databases | 0.302887 |
| sentinel surveillance incidence | 0.498776 |
| influenza sentinel hospital | 0.416138 |
| hospital catchment area | 0.411435 |
| probable bacterial meningitis | 0.556559 |
| nonsentinel hospitals | 0.333691 |
| IB-VPD sentinel hospital | 0.527822 |
| sentinel hospital catchment | 0.570084 |
| meningitis hospitalization rates | 0.66208 |
| meningitis patients | 0.563926 |
| Annual meningitis hospitalization | 0.503768 |
| meningitis patients reside | 0.486181 |
| geographical catchment area | 0.336103 |
| hospital surveillance data | 0.32569 |
| catchment area | 0.683962 |
|
| IB-VPD surveillance | 0.464582 |
| laboratory-confirmed pneumococcal meningitis | 0.457459 |
| sentinel hospital surveillance | 0.722665 |
| sentinel hospital | 0.985628 |
| large sentinel hospitals | 0.386309 |
| Global Invasive Bacterial | 0.323795 |
| administrative population estimates | 0.318551 |
| meningitis admissions | 0.430326 |
| annual sentinel hospitalization | 0.385773 |
| at-risk children | 0.307168 |
| sentinel hospitals | 0.49193 |
| catchment area residents | 0.361222 |
| Invasive Bacterial Vaccine-Preventable | 0.324747 |
| population estimates | 0.326311 |
| hospital surveillance network | 0.355848 |
| meningitis | 0.847126 |
| sentinel surveillance | 0.513372 |
| meningitis incidence rates | 0.619493 |
| sentinel hospital records | 0.418724 |
| suspected meningitis | 0.484023 |
| actual meningitis incidence | 0.471363 |
| meningitis cases | 0.43896 |
| routine childhood immunization | 0.323381 |
| IB-VPD surveillance network | 0.440586 |
|
CLICK HERE |
| 10178 |
Centers for Disease Control and Prevention |
Html |
es |
Listas de verificación|Temporada invernal |
Tomar medidas preventivas es su mejor protección contra las temperaturas frías extremas. Usted puede reducir el riesgo de sufrir afecciones atribuidas a las condiciones climáticas si prepara su casa y auto con antelación para las emergencias de invierno y si toma precauciones de seguridad durante las temperaturas extremadamente frías. |
| Servicio Meteorológico Nacional | 0.861376 |
| fuertes vientos | 0.76781 |
| Archivo Apple Quicktime | 0.807367 |
| National Oceanic | 0.76262 |
| frÃo extremo | 0.758824 |
| siguientes artÃculos | 0.762396 |
| Archivo Microsoft PowerPoint | 0.822664 |
| Archivo Adobe PDF | 0.805674 |
|
| Atmospheric Administration | 0.771264 |
| Archivo Microsoft | 0.987617 |
| Archivo Microsoft Word | 0.820288 |
| siguientes fuentes | 0.735514 |
| Archivo Zip Comprimido | 0.804501 |
| Archivo Microsoft Excel | 0.803798 |
| Anticipe temperaturas | 0.76915 |
|
CLICK HERE |
| 10515 |
Centers for Disease Control and Prevention |
Html |
en |
Email Updates: October 22, 2012'Clinicians Outreach and Communication Activity (COCA) |
CDC Clinician Outreach and Communication Activity (COCA). Providing clinicians the most current and reliable information on emerging public health threats, such as pandemics, natural disasters, and bioterrorism. |
| CDC | 0.945426 |
| Travel Warnings | 0.479706 |
| Public Health Matters | 0.498245 |
| Emergency Preparedness | 0.481884 |
| natural disasters | 0.50172 |
| FDA Safety Information | 0.538087 |
| Nile virus infections | 0.477348 |
| prevention science | 0.406608 |
| unopened medication vials | 0.469576 |
| Outbreak Investigation | 0.429284 |
| CDC Science Clips | 0.721192 |
| Additional COCA Conference | 0.550592 |
| CDC Influenza Division | 0.686966 |
| important safety information | 0.478867 |
| subject matter experts | 0.5015 |
| Free CE credit/contact | 0.50084 |
| Weekly Flu View | 0.476643 |
| human medical products | 0.469909 |
| EID Home Page | 0.492332 |
| England Compounding Center | 0.65358 |
| infected patients | 0.407004 |
| Current Travel Warnings | 0.478954 |
| FDA gateway | 0.44454 |
| preservative-free methylprednisolone acetate | 0.67257 |
| Event Reporting Program | 0.475851 |
|
| clinical presentation | 0.412613 |
| New England Compounding | 0.652621 |
| fungal meningitis | 0.834243 |
| Multistate Fungal Meningitis | 0.59143 |
| epidural steroid injection | 0.495617 |
| multi-state investigation | 0.410791 |
| weekly feature | 0.408174 |
| Patient Notification Letter | 0.473757 |
| Fungal Meningitis Outbreak | 0.737529 |
| COCA Email Update | 0.555544 |
| west nile virus | 0.722 |
| current epidemiology | 0.41038 |
| public health community | 0.500063 |
| Patient Notification Advised | 0.470057 |
| public health | 0.545962 |
| FDA Statement | 0.447116 |
| Specific Hazards preparedness | 0.493501 |
| in-person training centers | 0.480963 |
| Nile virus disease | 0.479763 |
| Pet Sense Disasters | 0.492301 |
| FoodSafety.gov Reports FDA | 0.536209 |
| weekly influenza surveillance | 0.475751 |
| USDA Food Recalls | 0.47464 |
| Response Training Resources | 0.491513 |
|
CLICK HERE |
| 13208 |
Centers for Disease Control and Prevention |
Image |
null |
Top Diseases and Risk Factors for Hispanics |
null |
|
|
CLICK HERE |
| 13906 |
Centers for Disease Control and Prevention |
Html |
null |
Vital Signs: Estimated Percentages and Numbers of Adultswith Indications for Preexposure Prophylaxis to Prevent HIVAcquisition - United States, 2015 |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). Often called 'the Voice of CDC,' the MMWR series is the agency's primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. MMWR readership predominately consists of physicians, nurses, public health practitioners, epidemiologists and other scientists, researchers, educators, and laboratorians. |
|
|
CLICK HERE |